Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injury.
Marcus J GeraldValerie Bracchi-RicardJerome RicardRoman FischerBharadwaj NandakumarGary H BlumenthalRaushaun WilliamsRoland E KontermannKlaus PfizenmaierKaren A MoxonJohn R BetheaPublished in: CNS neuroscience & therapeutics (2019)
The activation of TNFR2 in the spinal cord following contusive injury leads to enhanced locomotion and better cortical responses to hindlimb stimulation.